STOCK TITAN

Dr. William Gueck reports aggregated 5% stake in Mesoblast via ADR holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Dr. William Gueck reported beneficial ownership of 64,521,900 Ordinary Shares of Mesoblast Ltd held in the form of American Depositary Receipts (ADRs), representing approximately 5.0% of the company's outstanding Ordinary Shares based on 1,281,167,187 shares outstanding. He is the sole beneficial owner of 525,000 ADRs and reports discretionary authority over additional ADRs held by family members, trusts and entities, including 49,717,450 ADRs held by Cova Holdings LP, 350,000 ADRs underlying exercisable warrants held by Cova Holdings LP, and 8,345,150 ADRs held by AVCO Holdings LP. The filing disclaims admission of beneficial ownership of shares held by the identified entities.

Positive

  • Clear disclosure of aggregated beneficial ownership totaling 64,521,900 ADR-form Ordinary Shares (~5.0% of outstanding shares)
  • Transparency on composition of holdings, showing direct ownership and discretionary authority over family, trust and entity positions including Cova Holdings LP and AVCO Holdings LP

Negative

  • None.

Insights

TL;DR: Disclosure notifies the market that an individual may control roughly 5% of Mesoblast via ADRs and related entities, a material ownership stake.

This Schedule 13G reports aggregated beneficial ownership of 64,521,900 ADR-form Ordinary Shares, about 5.0% of issued shares. The filing clarifies direct ownership (525,000 ADRs) and extensive discretionary control over ADRs held by family members, trusts and two holding entities, including a large position at Cova Holdings LP. For investors and market participants, the filing increases transparency about concentration of holdings and potential voting influence without asserting an intent to change control.

TL;DR: The disclosure highlights governance relevance due to consolidated voting/dispositive authority across related parties and entities.

The report details discretionary voting and disposition authority over multiple accounts and vehicles, which is important for governance analysis because it aggregates influence beyond the Reporting Person's sole holdings. The explicit disclaimer regarding beneficial ownership of entity-held shares is standard, but the aggregation disclosed here should prompt stakeholders to note where voting power may be concentrated.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) The number of Ordinary Shares reported is as of September 12, 2025. The Reporting Person is the sole beneficial owner of 525,000 Ordinary Shares held in the form of American Depositary Receipts ("ADRs"). The Reporting Person also has discretionary authority to vote and dispose, and may be deemed to be the beneficial owner, of: (i) 1,792,150 Ordinary Shares held in the form of ADRs by Conrad Gueck; (ii) 1,792,150 Ordinary Shares held in the form of ADRs by Ava Gueck; (iii) 1,110,000 Ordinary Shares held in the form of ADRs by the Mary DeAnn Gueck trust, for which the Reporting Person is trustee; (iv) 890,000 Ordinary Shares held in the form of ADRs by the William Gueck trust, for which Mary DeAnn Gueck is trustee. In addition, the Reporting Person has discretionary authority to vote and dispose of (A) 49,717,450 Ordinary Shares held in the form of ADRs by Cova Holdings LP and (B) 350,000 Ordinary Shares in the form of ADRs underlying warrants that Cova Holdings LP has the right to acquire through the exercise of such warrants within 60 days, and may be deemed to be the beneficial owner of these shares. In addition, the Reporting Person has discretionary authority to vote and dispose of 8,345,150 Ordinary Shares held in the form of ADRs by AVCO Holdings LP and may be deemed to be the beneficial owner of these shares.


SCHEDULE 13G



Gueck William J.
Signature:/s/ William Gueck
Name/Title:Dr. William Gueck
Date:09/16/2025

FAQ

What stake in Mesoblast (MEOBF) does Dr. William Gueck report?

Dr. William Gueck reports beneficial ownership of 64,521,900 ADR-form Ordinary Shares, representing approximately 5.0% of the outstanding Ordinary Shares.

How many shares does Dr. Gueck directly own versus control indirectly?

He is the sole beneficial owner of 525,000 ADRs; the remainder reflects shares over which he has discretionary authority held by family members, trusts and entities.

Which entities' holdings are included in the reported total?

The filing cites discretionary authority over holdings including 49,717,450 ADRs held by Cova Holdings LP, 8,345,150 ADRs held by AVCO Holdings LP, and additional family/trust holdings and warrants.

Does the filing admit ownership of shares held by the entities named?

No. The filing includes an explicit disclaimer that it does not constitute an admission that the Reporting Person is the beneficial owner of shares held by Cova Holdings LP or AVCO Holdings LP.

On what outstanding share base is the percentage ownership calculated?

The percentage is calculated using 1,281,167,187 Ordinary Shares issued and outstanding as stated in the filing.